| RS2529972387 |
LRAT
|
Health Risk |
Pathogenic |
— |
| RS2529972515 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529972867 |
ARL6
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 55, Bardet-Biedl syndrome 3 |
| RS2529973359 |
LRAT
|
Health Risk |
Pathogenic |
— |
| RS2529974016 |
ARL6
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 3, Retinitis pigmentosa 55 |
| RS2529974081 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529974099 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS2529974111 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS2529974215 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529974319 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
PCCB-related disorder, Propionic acidemia |
| RS2529974362 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529975182 |
ARL6
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 3, Retinitis pigmentosa 55 |
| RS2529977115 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529977421 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529980257 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529980304 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529980344 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2529994767 |
LHCGR
|
Health Risk |
Likely pathogenic |
— |
| RS2530008022 |
STAG1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS2530014641 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530014786 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530021619 |
STAG1
|
Health Risk |
Likely pathogenic |
— |
| RS2530023546 |
ANKRD17
|
Health Risk |
Likely pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS2530025111 |
LOXL3
|
Health Risk |
Pathogenic |
Myopia 28, autosomal recessive |
| RS2530031168 |
STAG1
|
Health Risk |
Likely pathogenic |
— |
| RS2530032021 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530032256 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530032320 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530032498 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2530033254 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS2530033753 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2530033946 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2530034050 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2530034152 |
TREX1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2530034759 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2530034972 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2530035923 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS2530037311 |
TREX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 1, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS2530038411 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2530038732 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2530040403 |
TREX1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 1, Aicardi-Goutieres syndrome 1 |
| RS2530040771 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2530041483 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS2530041997 |
TREX1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 1, Aicardi-Goutieres syndrome 1 |
| RS2530042757 |
TREX1
|
Health Risk |
Likely pathogenic |
— |
| RS2530043474 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530043718 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530045961 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2530046089 |
TREX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 1, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS2530048530 |
TREX1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2530057514 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530057605 |
MCCC1
|
Health Risk |
Likely pathogenic |
MCCC1-related disorder, MCCC1-related disorder |
| RS2530057792 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530063503 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2530068462 |
GLRB
|
Health Risk |
Pathogenic |
Hyperekplexia 2, Hyperekplexia 2 |
| RS2530068914 |
GLRB
|
Health Risk |
Pathogenic |
Hyperekplexia 2, Hyperekplexia 2 |
| RS2530075944 |
SEC24D
|
Health Risk |
Pathogenic |
— |
| RS2530076755 |
SEC24D
|
Health Risk |
Pathogenic |
— |
| RS2530078152 |
STAG1
|
Health Risk |
Pathogenic |
— |
| RS2530082710 |
GLRB
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2530083642 |
FAT4
|
Health Risk |
Pathogenic/Likely pathogenic |
Hennekam lymphangiectasia-lymphedema syndrome 2, Hennekam lymphangiectasia-lymphedema syndrome 2 |
| RS2530086166 |
SCLT1
|
Health Risk |
Pathogenic |
— |
| RS2530086190 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2530101395 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530101486 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530101552 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530102458 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530126061 |
TTN
|
Health Risk |
Likely pathogenic |
TTN-related disorder, TTN-related disorder |
| RS2530127005 |
FBXW7
|
Health Risk |
Likely pathogenic |
Developmental delay, hypotonia |
| RS2530128064 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530130369 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530136674 |
SEC24D
|
Health Risk |
Likely pathogenic |
Cole-Carpenter syndrome 2, Cole-Carpenter syndrome 2 |
| RS2530145157 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530166738 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530166841 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530166964 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530169373 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2530190552 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2530191471 |
FBXW7
|
Health Risk |
Likely pathogenic |
Developmental delay, hypotonia |
| RS2530194325 |
USP53
|
Health Risk |
Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2530194420 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530195072 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530206539 |
SEC24D
|
Health Risk |
Likely pathogenic |
Cole-Carpenter syndrome 2, Cole-Carpenter syndrome 2 |
| RS2530214673 |
BMPR1B
|
Health Risk |
Likely pathogenic |
Type A2 brachydactyly, Acromesomelic dysplasia 3 |
| RS2530218156 |
FBXW7
|
Health Risk |
Likely pathogenic |
FBXW7-related disorder, FBXW7-related disorder |
| RS2530219785 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
TTN-related disorder, TTN-related disorder |
| RS2530223985 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2530229386 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2530234915 |
FBXW7
|
Health Risk |
Likely pathogenic |
Developmental delay, hypotonia |
| RS2530246729 |
SEC24D
|
Health Risk |
Pathogenic |
— |
| RS2530259419 |
NAA15
|
Health Risk |
Pathogenic |
— |
| RS2530259652 |
NAA15
|
Health Risk |
Likely pathogenic |
— |
| RS2530264975 |
USP53
|
Health Risk |
Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2530267413 |
SEC24D
|
Health Risk |
Pathogenic |
— |
| RS2530272868 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530273568 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530273629 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530274504 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530278731 |
UBA5
|
Health Risk |
Pathogenic |
— |
| RS2530286004 |
SEC24D
|
Health Risk |
Pathogenic |
— |